top of page
Virus Studies

Oncology Panel

Cancer is an increasing health challenge in India, with the number of cancer cases projected to go up from 14.6 lakh in 2022 to 15.7 lakh in 2025, according to ICMR-NCRP.

 

Advances in diagnostic technology aids in the early detection of cancer. Real-time PCR technology is a highly sensitive method not only for detection but also for characterization of minimal residual disease from samples of patients with cancer. RT-PCR shows high sensitivity and specificity for a known fusion transcript.

PML-RARA Qualitative Real-Time PCR Kit.avif
PML-RARA Qualitative
Real-Time PCR Kit

Used for qualitative detection of PML-RARA transcripts (bcr1, bcr2 & bcr3)

in RNA extracted from peripheral blood

or bone marrow aspirates

PML-RARA Quantitative Real-Time PCR Kit.avif
PML-RARA Quantitative
Real-Time PCR Kit

Used for specific differentiation and quantification of PML-RARA transcripts: bcr1 (long)/bcr2 (variant) and bcr3 (short) in RNA extracted from peripheral blood or bone marrow aspirates

bottom of page